The current study investigated changes in the blood parameters and levels of the two tumor biomarkers (CEA and LDH) due to intermittent fasting during the month of Ramadan in CRC patients receiving chemotherapy. The gene discussed is CEACAM5; the disease is colorectal carcinoma.